Back to YC Companies
Eris Biotech
Winter 2024
Active
Our drugs engage the immune system to fight tumors
2 people View on YC
Eris Biotech at a glance
- Y Combinator batch
- Winter 2024
- Status
- Active
- Industry
- Healthcare
- Team size
- 2 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Eris Biotech
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
Tags:
Biotech
Therapeutics
Drug discovery
Oncology